Adverse effects of antiepileptic drugs on bone mineral density

Arzu Babayigit1, Eray Dirik, Ece Bober

  • 1Department of Pediatrics, Division of Neurology, Dokuz Eylul University Medical Faculty, Izmir, Turkey. arbabyigit@yahoo.com

Pediatric Neurology
|August 31, 2006
PubMed

Insights

Long-term use of antiepileptic drugs like valproic acid, carbamazepine, and oxcarbazepine in children with epilepsy is linked to lower bone mineral density. These medications may affect bone metabolism, warranting further investigation.

Area of Science:

  • Pediatric Endocrinology
  • Neurology
  • Pharmacology

Background:

  • Epilepsy is a common neurological disorder in children.
  • Antiepileptic drugs (AEDs) such as valproic acid, carbamazepine, and oxcarbazepine are standard treatments for epilepsy.
  • Concerns exist regarding the long-term effects of AEDs on bone health in pediatric populations.

Purpose of the Study:

  • To investigate the impact of valproic acid, carbamazepine, and oxcarbazepine on bone metabolism markers.
  • To assess bone mineral density (BMD) in children with idiopathic epilepsy on long-term AED treatment.
  • To compare biochemical bone markers and BMD between epileptic children on AEDs and healthy controls.

Main Methods:

  • Cross-sectional study involving 68 children with idiopathic epilepsy on AEDs (carbamazepine, valproic acid, or oxcarbazepine) for over 1 year and 30 healthy controls.
  • Blood samples analyzed for calcium, phosphorus, alkaline phosphatase, parathormone, and 25-hydroxyvitamin D.
  • Bone mineral density measured using dual-energy x-ray absorptiometry (DXA).

Main Results:

  • No significant differences in serum calcium, phosphorus, liver enzymes, or albumin between groups.
  • Elevated serum alkaline phosphatase levels observed in the AED-treated patient group compared to controls.
  • Significantly lower bone mineral density values in children receiving AEDs compared to healthy children.

Conclusions:

  • Long-term treatment with valproic acid, carbamazepine, or oxcarbazepine is associated with reduced bone mineral density in children.
  • AED therapy may negatively impact skeletal mineralization.
  • Further research is needed to elucidate the precise mechanisms and long-term skeletal consequences of these AEDs in pediatric epilepsy.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...